TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
URGN

UroGen Pharma Ltd

Healthcare · Biotechnology

42.80$ -1.0% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet URGN
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
+344.8% +18.9% +227.7% +37.1% +95.4% -39.7% -1.9% +13.3% +31.5% +60.2% -29.8%
+346.2% +15.2% +237.9% +37.3% +45.4% -22.2% -1.1% +12.7% +31.2% +63.2% -32.6%
+364.5% +18.8% +73.2% +173.8% -51.0% +6.4% -16.1% +24.9% +71.5% +81.0% -35.6%
+364.5% +18.8% +241.7% +38.8% +45.2% -30.6% -12.6% +12.1% +37.0% +72.8% -49.1%
+138.6% +66.3% +8.4% +21.6% +31.5% +62.9%
+201.0% +146.0% -10.5% +31.2% +62.6% +78.4%
+264.8% +186.1% +8.6% +17.8% +397.0% -10.8% -53.2% -34.1%
+151.1% +201.7% +4.2% +91.4% +64.0% +16.1% +334.0% +102.1% +8.2% +20.9% +3.9%
+151.1% +40.2% +124.3% +91.4% +44.7% +10.0% +4.4% +6.9% +30.5% +47.2% +1.0%
+79.1% -71.7% -13.0% +86.8%
+234.5% +9.6% +51.0% +50.5% +9.9% -30.3% +76.9% -4.5% +17.9% +67.8% +11.0%
+314.2% +1.0% +23.5% +0.4%
+394.6% -4.9% +320.2% +31.5% +100.1% -46.6% -91.3% -1,162.2%
+0.1% +419.9% -18.8% +62.1% +30.3% +6.1% +2.6% +2.1% +26.4% +48.7% +12.2%

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?